Goldman Sachs’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-25,481
Closed -$85K 7626
2015
Q4
$85K Sell
25,481
-62,721
-71% -$182K ﹤0.01% 6271
2015
Q3
$207K Sell
88,202
-18,004
-17% -$43.2K ﹤0.01% 5998
2015
Q2
$241K Buy
+106,206
New +$308K ﹤0.01% 5966
2014
Q4
Sell
-35,313
Closed -$111K 7491
2014
Q3
$111K Sell
35,313
-51,443
-59% -$163K ﹤0.01% 6533
2014
Q2
$325K Buy
86,756
+74,047
+583% +$288K ﹤0.01% 5739
2014
Q1
$50K Buy
+12,709
New +$55.7K ﹤0.01% 6561

Goldman Sachs's LBMH Position: Q1 2016 in Review

Goldman Sachs sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 25,481 shares — an estimated $85K sold.

Goldman Sachs first reported a position in LBMH in Q1 2014 and held it in 6 quarters. The position peaked at $325K in Q2 2014. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

  • Goldman Sachs reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
  • Goldman Sachs sold 25,481 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016, an estimated $85K.
  • Goldman Sachs first reported a position in LIBERATOR MED HLDGS INC (NY) in Q1 2014 and held it in 6 quarters.
  • Goldman Sachs's LIBERATOR MED HLDGS INC (NY) position peaked at $325K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.